| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | JUNO THERAPEUTICS INCORPORATED | 1,602,562 | 61,042,000 | 83.87% | ||
| 2 | ADMA BIOLOGICS, INC. | 1,433,304 | 11,595,000 | 15.93% | ||
| 3 | MABVAX THERAPEUTICS HOLDINGS, INC. | 197,641 | 142,000 | 0.20% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0000950123-16-017825, filed 2016.06.01).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
